Get the Stockscreener App
1.60
2.44%
-0.04
Pre-market:
1.61
0.01
+0.63%
Pacific Biosciences Of California Inc Stock (PACB) Latest News
Pacific Biosciences of California (PACB) Projected to Post Earnings on Thursday - MarketBeat
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why - MSN
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service - GlobeNewswire
Tech & Life Sciences Veteran David Ruggiero Takes Helm of PacBio's Global Sales Strategy - StockTitan
Pacific Biosciences of California (NASDAQ:PACB) investors are sitting on a loss of 86% if they invested three years ago - Yahoo Finance
PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 - GlobeNewswire
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Impacting Market TrendsTechnavio - The Malaysian Reserve
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Driving Market TransformationTechnavio - The Malaysian Reserve
Menlo Park-based biotech company welcomes Florida exec to board - The Business Journals
Life sciences stocks fall on NIH funding concerns - MSN
Pacific Biosciences of California Appoints NeoGenomics CEO to Board of Directors -January 30, 2025 at 10:30 am EST - Marketscreener.com
Strategic Power Move: NeoGenomics CEO Joins PacBio Board to Accelerate Clinical Market Push - StockTitan
PACB (Pacific Biosciences of California) 5-Year Dividend Gr - GuruFocus.com
Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know - MSN
Revolutionary DNA Tech Cracks Medical Mystery That Stumped Traditional Testing - StockTitan
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now - MSN
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $2.95 Consensus Price Target from Analysts - Defense World
Assenagon Asset Management S.A. Has $390,000 Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Defense World
JPMorgan Chase & Co. Purchases 45,957 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Defense World
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now - MSN
The Goldman Sachs Group Issues Pessimistic Forecast for Pacific Biosciences of California (NASDAQ:PACB) Stock Price - Defense World
The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $1.75 - MarketBeat
What Analysts Are Saying About Pacific Biosciences Stock - Benzinga
PacBio Expands HiFi Sequencing Network: GIFS Becomes First Canadian Certified Provider - StockTitan
Analysts Set Pacific Biosciences of California, Inc. (NASDAQ:PACB) PT at $2.95 - MarketBeat
Brokers Issue Forecasts for PACB FY2025 Earnings - MarketBeat
Cantor Fitzgerald Comments on PACB FY2025 Earnings - Defense World
PACB Stock Falls on Preliminary Q4 Sales Miss, 7 Vega Systems Shipped - MSN
Pacific Biosciences of California (NASDAQ:PACB) Trading 8.5% HigherShould You Buy? - MarketBeat
Cantor Fitzgerald Weighs in on PACB FY2025 Earnings - MarketBeat
PACB Stock Rises After the Shipment of Vega Systems to Berry Genomics - MSN
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report - GlobeNewswire Inc.
Chromosome-level genome assembly of the pine wood nematode carrier Arhopalus unicolor - Nature.com
PacBio announces preliminary Q4 revenue of $39.2M - MSN
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap DownShould You Sell? - MarketBeat
PacBio Stock May Gain Following the Collaborated Launch of GutID - MSN
PACB Stock Declines Despite Promising HiFi Sequencing Findings - Yahoo Finance
Don't Ignore The Insider Selling In Pacific Biosciences of California - Simply Wall St
Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St
Barclays PLC Has $1.01 Million Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Defense World
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by Barclays PLC - MarketBeat
PacBio reports drop in annual revenue, launches new products By Investing.com - Investing.com Canada
PacBio reports drop in annual revenue, launches new products - Investing.com India
PacBio's HiFi Sequencing Achieves 93% Success Rate in Breakthrough Rare Disease Study - StockTitan
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue - Quantisnow
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):